3.3 Newborn Screening & Diagnostic Imaging Modalities

3.3 Newborn Screening & Diagnostic Imaging Modalities

Universal newborn screening and bedside diagnostic imaging are cornerstones of neonatal preventative and acute clinical care. Timely detection of inborn errors of metabolism, critical congenital heart defects, hearing loss, and acute cardiopulmonary or surgical emergencies prevents catastrophic neurological disability, irreversible organ damage, and neonatal mortality.

1. Universal Newborn Dried Blood Spot Screening

State-mandated universal newborn screening utilizes dried blood spot specimens collected on specialized filter paper cards (Guthrie cards) to screen for dozens of congenital disorders on the federal Recommended Uniform Screening Panel (RUSP).

Timing & Specimen Collection Technique

• Optimal Timing: Between 24 and 48 hours of life, and prior to hospital discharge. The infant must have received sufficient enteral protein/milk feeds (usually for at least 24 hours) to allow metabolic substrates (such as phenylalanine or leucine) to accumulate to detectable diagnostic thresholds.
• Early Discharge Protocol ($< 24$ Hours): If the specimen is collected before 24 hours of life (e.g., in early discharge or prior to emergent packed RBC transfusion), the initial screen is considered invalid for certain metabolic disorders and must be repeated within 1 to 2 weeks of life.
• Preterm / Sick Infants: Protocols mandate serial screening (e.g., initial screen at admission/24-48h, second screen at 14 days of life, and third screen at discharge or 28 days).
• Heelstick Collection Technique: The puncture site must be restricted to the medial or lateral plantar borders of the heel (external to lines drawn posteriorly from the 4th-5th interdigital space and middle of the great toe). Puncturing the central plantar arch or posterior heel curvature risks hitting the calcaneus bone, causing calcaneal osteomyelitis. Drops of blood must fully soak through and saturate both sides of the filter paper circle without layering, smudging, or applying blood via capillary tubes containing anticoagulants. Cards are air-dried horizontally on a flat surface for 3 to 4 hours away from direct heat and sunlight.

Core Condition Categories on the RUSP Panel

1. Inborn Errors of Amino Acid Metabolism:

   • Phenylketonuria (PKU): Deficiency of phenylalanine hydroxylase, preventing conversion of phenylalanine to tyrosine. Toxic accumulation of phenylalanine causes severe, irreversible intellectual disability, microcephaly, seizures, and musty/mousy odor. Treatment: Phenylalanine-restricted diet (specialized formula and low-protein foods) initiated within the first 1-2 weeks of life.
   • Maple Syrup Urine Disease (MSUD): Deficiency of branched-chain alpha-ketoacid dehydrogenase, leading to toxic buildup of branched-chain amino acids (leucine, isoleucine, valine). Presents in the first week with poor feeding, vomiting, lethargy, encephalopathy, bicycling limb movements, and a characteristic sweet maple syrup odor in the urine and cerumen. Leucine accumulation causes life-threatening cerebral edema.

2. Fatty Acid Oxidation Disorders:

   • Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency: Inability to oxidize medium-chain fatty acids for energy during periods of fasting or metabolic stress. Presents with hypoketotic hypoglycemia, lethargy, vomiting, liver dysfunction, and sudden death. Treatment: Avoid fasting, maintain frequent enteral feeds, and provide IV dextrose during illness.

3. Organic Acidemias (MMA, PA, IVA):

   • Methylmalonic acidemia (MMA), Propionic acidemia (PA), and Isovaleric acidemia (IVA) cause severe high anion gap metabolic acidosis, marked hyperammonemia, ketonuria, vomiting, and coma in the first days of life. Isovaleric acidemia causes a distinct "sweaty feet" body odor.

4. Endocrine Disorders:

   • Congenital Hypothyroidism (CH): The most common preventable cause of intellectual disability. Caused by thyroid dysgenesis or dyshormonogenesis. Elevated Thyroid-Stimulating Hormone (TSH) with low free $\text{T}_4$. If untreated, leads to cretinism, coarse facial features, large protruding tongue, umbilical hernia, hypotonia, and severe cognitive delay. Treatment: Daily oral Levothyroxine ($\text{Synthroid}$) initiated immediately.
   • Congenital Adrenal Hyperplasia (CAH): Most commonly caused by 21-hydroxylase deficiency, leading to blocked cortisol and aldosterone synthesis and massive adrenal androgen overproduction (elevated 17-hydroxyprogesterone [17-OHP]). Genetically female (46,XX) neonates present with ambiguous genitalia (clitoromegaly, labial fusion). In classic salt-wasting CAH, severe deficiency of aldosterone leads to an acute salt-wasting adrenal crisis at 1 to 2 weeks of life, presenting with profound hyponatremia, severe hyperkalemia, dehydration, hypotension, and shock. Treatment: Emergency fluid resuscitation and lifelong hydrocortisone plus fludrocortisone replacement.

5. Hemoglobinopathies:

   • Sickle Cell Disease (Hb SS, Hb SC, Hb S-beta thalassemia): Identified via isoelectric focusing or HPLC. Affected neonates are asymptomatic at birth due to high fetal hemoglobin (HbF). Early identification allows initiation of daily prophylactic oral Penicillin V at 2 months of age, which reduces the incidence of invasive, fatal Streptococcus pneumoniae sepsis by $> 80%$.

6. Carbohydrate Disorders:

   • Classic Galactosemia: Deficiency of galactose-1-phosphate uridylyltransferase (GALT enzyme), preventing the breakdown of galactose (a component of lactose found in breast milk and cow's milk formula). Toxic galactose-1-phosphate accumulates in tissues upon feeding. Presents within days of life with vomiting, diarrhea, rapid severe jaundice, hepatomegaly, liver failure, bilateral nuclear cataracts, and an overwhelmingly high susceptibility to systemic Escherichia coli (E. coli) sepsis. Treatment: Immediate, complete, and permanent elimination of all lactose and galactose from the diet (immediate switch to a soy-based or elemental formula).

7. Pulmonary, Immune, & Neuromuscular Disorders:

   • Cystic Fibrosis (CF): Screened via elevated Immunoreactive Trypsinogen (IRT) on dried blood spots, followed by second-tier DNA analysis for CFTR mutations (e.g., $\Delta\text{F508}$). Confirmed by sweat chloride testing ($> 60\text{ mEq/L}$).
   • Severe Combined Immunodeficiency (SCID): Quantifies T-cell Receptor Excision Circles (TRECs) in dried blood spots. Absence of functional T-cells and B-cells leaves the infant completely defenseless against lethal infections. Live viral vaccines (Rotavirus) are strictly contraindicated. Requires strict isolation, irradiated/leukoreduced CMV-negative blood products, and hematopoietic stem cell transplantation.
   • Spinal Muscular Atrophy (SMA): Identifies homozygous deletion of the SMN1 gene, allowing early initiation of disease-modifying gene therapies (e.g., Onasemnogene abeparvovec / Zolgensma or Nusinersen) before irreversible motor neuron loss occurs.

2. Critical Congenital Heart Disease (CCHD) Screening

Pulse oximetry screening for Critical Congenital Heart Disease (CCHD) identifies asymptomatic newborns with life-threatening cyanotic or ductal-dependent cardiac lesions before ductus arteriosus closure causes acute circulatory collapse and death.

The 7 Primary Target CCHD Lesions

1. Hypoplastic Left Heart Syndrome (HLHS)
2. Pulmonary Atresia (with intact septum)
3. Tetralogy of Fallot (TOF)
4. Total Anomalous Pulmonary Venous Return (TAPVR)
5. Transposition of the Great Arteries (TGA)
6. Tricuspid Atresia
7. Truncus Arteriosus

Screening Protocol & Sensor Placement

• Timing: Performed at $\ge 24$ hours of life (to minimize false-positive rates during normal transitional pulmonary vascular resistance decline) or immediately prior to discharge if discharged $< 24$ hours.
• Sensor Sites:
  • Pre-ductal: Must be placed on the Right Hand.
  • Post-ductal: Placed on Either Foot (Left or Right).
• Algorithm Interpretation Rules:
  • PASS: $\text{SpO}_2 \ge 95%$ in BOTH the right hand and foot AND an absolute difference of $\le 3%$ between the right hand and foot.
  • IMMEDIATE FAIL: Any $\text{SpO}_2 < 90%$ in either the right hand or the foot.
  • REPEAT (Equivocal): $\text{SpO}_2$ between $90% - 94%$ in the right hand or foot, OR a $> 3%$ absolute difference between hand and foot. The test must be repeated in 1 hour (up to 3 total screenings). If the third screen still yields an equivocal result ($90-94%$ or $> 3%$ difference), it is classified as a FAIL.
  • Action on Fail: Immediate physical assessment of vital signs and peripheral pulses, continuous cardiorespiratory monitoring, immediate notification of the neonatologist/pediatrician, and emergent pediatric echocardiogram.

3. Early Hearing Detection and Intervention (EHDI) 1-3-6 Guidelines

Congenital hearing impairment occurs in $1-3$ per 1,000 live births. The Joint Committee on Infant Hearing (JCIH) establishes the national "1-3-6" EHDI Benchmarks:

• 1 Month: All newborns must complete universal physiologic hearing screening before 1 month of age (prior to discharge).
• 3 Months: All infants who fail ("refer" on) hospital screening must receive a comprehensive diagnostic audiological evaluation before 3 months of age.
• 6 Months: All infants diagnosed with confirmed hearing loss must initiate early intervention and speech/language services before 6 months of age.

Hearing Screening Modalities

4. Diagnostic Imaging: Radiography & Cranial Ultrasound

Chest Radiography (CXR): Differentiating Neonatal Pulmonary Pathologies

1. Respiratory Distress Syndrome (RDS):
   • Symmetrical, diffuse "ground-glass" reticulogranular opacities, hypoaeration (low lung volumes with $< 8$ posterior ribs visible), and prominent air bronchograms (air-filled bronchi outlined by collapsed, atelectatic alveoli).
2. Transient Tachypnea of the Newborn (TTN):
   • Lung hyperinflation ($> 8-9$ posterior ribs visible, flattened diaphragmatic domes), prominent symmetrical perihilar interstitial streakiness ("sunburst pattern" representing engorged lymphatic channels), and fluid accumulation in the interlobar fissures.
3. Meconium Aspiration Syndrome (MAS):
   • Marked hyperexpansion alternating with areas of coarse, patchy atelectasis (rope-like asymmetric infiltrates); high incidence of air leak complications (pneumothorax / pneumomediastinum in $15-30%$ of cases).
4. Neonatal Pneumothorax:
   • Hyperlucent pleural space completely devoid of vascular and parenchymal lung markings; sharp, visible visceral pleural line; contralateral mediastinal shift.
   • On supine CXR: The "Deep Sulcus Sign" (an abnormally deepened, hyperlucent, sharply angled costophrenic sulcus) or anterior medial lucency.

Radiographic Landmarks for Invasive Line & Tube Placement

Bedside Cranial Ultrasound & Intraventricular Hemorrhage (IVH)

Cranial ultrasound is performed through the anterior fontanelle in coronal and parasagittal planes. It is the primary neuroimaging modality for evaluating germinal matrix-intraventricular hemorrhage and white matter injury in preterm infants.

• Papile Classification of Intraventricular Hemorrhage:
  • Grade I: Subependymal germinal matrix hemorrhage without intraventricular extension.
  • Grade II: Intraventricular hemorrhage without ventricular dilatation (occupying $< 50%$ of lateral ventricular area).
  • Grade III: Intraventricular hemorrhage with acute lateral ventricular dilatation/enlargement.
  • Grade IV (Periventricular Hemorrhagic Infarction - PHI): Large intraventricular hemorrhage associated with venous infarction and parenchymal hemorrhage into the periventricular cerebral white matter.
• Periventricular Leukomalacia (PVL): Hypoxic-ischemic necrosis of white matter adjacent to the lateral ventricles. Appears initially as periventricular hyperechogenicity ("flaring") at 1 to 2 weeks, which evolves into diagnostic cystic cavitation ("cystic PVL") at 4 to 6 weeks of life. Strongest neuroimaging predictor of spastic diplegia cerebral palsy.

Abdominal Radiography (KUB): Necrotizing Enterocolitis & Bowel Perforation

• Normal Bowel Pattern: Polygonal, mosaic distribution of gas throughout the abdomen within 24 hours of life.
• Necrotizing Enterocolitis (NEC):
  • Pneumatosis Intestinalis: Pathognomonic linear or bubbly radiolucent gas collections within the subserosal or submucosal bowel wall ("train-track" appearance; Bell Stage II).
  • Portal Venous Gas: Branching, linear dendritic radiolucencies extending from the porta hepatis out into the peripheral hepatic parenchyma (Bell Stage IIB/III).
• Pneumoperitoneum (Gastrointestinal Perforation - Bell Stage IIIB):
  • Supine View: "Football Sign" (massive free peritoneal air outlining the entire peritoneal cavity as a large oval lucency, highlighting the falciform ligament in the center) and "Rigler Sign" (visualization of both the inner mucosal and outer serosal borders of the bowel wall).
  • Horizontal Beam View (Cross-Table Lateral or Left Lateral Decubitus): Essential view in suspected perforation; clearly demonstrates free extraluminal subdiaphragmatic or anterior abdominal wall air.